Acute and Interventional Treatments

HomeStrokeVol. 54, No. 2Acute and Interventional Treatments No AccessArticle CommentaryRequest AccessFull TextAboutView Full TextView PDFView EPUBSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toNo AccessArticle CommentaryRequest AccessFull TextAcute and Interventional Treatments Bruce C.V. Campbell, Michael D. Hill, Thanh N. Nguyen and Joseph P. Broderick Bruce C.V. CampbellBruce C.V. Campbell Correspondence to: Bruce C.V. Campbell, MBBS, PhD, Department of Neurology, Royal Melbourne Hospital Victoria, Australia. Email E-mail Address: [email protected] https://orcid.org/0000-0003-3632-9433 Department of Medicine and Neurology, Royal Melbourne Hospital, University of Melbourne, Parkville, Australia (B.C.V.C.). Search for more papers by this author , Michael D. HillMichael D. Hill https://orcid.org/0000-0002-6269-1543 Department of Clinical Neurosciences, University of Calgary, Alberta, Canada (M.D.H.). Search for more papers by this author , Thanh N. NguyenThanh N. Nguyen https://orcid.org/0000-0002-2810-1685 Departments of Neurology and Radiology, Boston Medical Center, MA (T.N.N.). Search for more papers by this author and Joseph P. BroderickJoseph P. Broderick https://orcid.org/0000-0002-7323-7709 Department of Neurology, University of Cincinnati Gardner Neuroscience Institute, OH (J.P.B.). Search for more papers by this author Originally published23 Jan 2023https://doi.org/10.1161/STROKEAHA.122.041254Stroke. 2023;54:591–594FootnotesThe opinions expressed in this article are not necessarily those of the editors or of the American Heart Association.For Sources of Funding and Disclosures, see page 594.Correspondence to: Bruce C.V. Campbell, MBBS, PhD, Department of Neurology, Royal Melbourne Hospital Victoria, Australia. Email bruce.campbell@mh.org.auReferences1. Yoshimura S, Sakai N, Yamagami H, Uchida K, Beppu M, Toyoda K, Matsumaru Y, Matsumoto Y, Kimura K, Takeuchi M, et al. Endovascular therapy for acute stroke with a large ischemic region.NEJM. 2022; 386:1303–1313. doi: 10.1056/NEJMoa2118191CrossrefGoogle Scholar2. Olthuis SGH, van Oostenbrugge R, van Zwam W. A randomized trial of endovascular treatment of ischemic stroke for late arrivals.Int J Stroke. 2022; 17(issue 3_suppl: 14th World Stroke Congress, Singapore, 26–29 October 2022):50.Google Scholar3. Jovin TG, Li C, Wu L, Wu C, Chen J, Jiang C, Shi Z, Gao Z, Song C, Chen W, et al. Trial of thrombectomy 6 to 24 hours after stroke due to basilar-artery occlusion.NEJM. 2022; 387:1373–1384.doi: 10.1056/NEJMoa2207576CrossrefGoogle Scholar4. Tao C, Nogueira RG, Zhu Y, Sun J, Han H, Yuan G, Wen C, Zhou P, Chen W, Zeng G, et al. Trial of endovascular treatment of acute basilar-artery occlusion.NEJM. 2022; 387:1361–1372. doi: 10.1056/NEJMoa2206317CrossrefGoogle Scholar5. Fischer U, Roos YBWEM. Direct mechanical thrombectomy versus bridging therapy for acute ischemic stroke.Int J Stroke. 2022; 17(issue 3_suppl: 14th World Stroke Congress, Singapore, 26–29 October 2022):51.Google Scholar6. Menon BK, Buck BH, Singh N, Deschaintre Y, Almekhlafi MA, Coutts SB, Thirunavukkarasu S, Khosravani H, Appireddy R, Moreau F, et al; AcT Trial Investigators. Intravenous tenecteplase compared with alteplase for acute ischaemic stroke in canada (AcT).Lancet. 2022; 400:161–169. doi: 10.1016/S0140-6736(22)01054-6CrossrefGoogle Scholar7. Sarraj A, Hassan AE, Abraham M, Ribo M, Blackburn S, Chen M, Hussain MS, Pereira VM, Ortega-Gutierrez S, Sitton C, et al. A randomized controlled trial to optimize patient’s selection for endovascular treatment in acute ischemic stroke (SELECT2).Int J Stroke. 2022; 17:689–693. doi: 10.1177/17474930211035032CrossrefGoogle Scholar8. Nguyen TN, Klein P, Berberich A, Nagel S, Abdalkader M, Herning A, Chen Y, Huo X, Miao Z, Sheth SA, et al. Late window imaging selection for endovascular therapy of large vessel occlusion stroke.Stroke: Vasc Interv Neurol. 2022. In PressGoogle Scholar9. Langezaal LCM, van der Hoeven E, Mont’Alverne FJA, de Carvalho JJF, Lima FO, Dippel DWJ, van der Lugt A, Lo RTH, Boiten J, Lycklama ANGJ, et al. Endovascular therapy for stroke due to basilar-artery occlusion.NEJM. 2021; 384:1910–1920. doi: 10.1056/NEJMoa2030297CrossrefMedlineGoogle Scholar10. Liu X, Dai Q, Ye R, Zi W, Liu Y, Wang H, Zhu W, Ma M, Yin Q, Li M, et al; BEST Trial Investigators. Endovascular treatment versus standard medical treatment for vertebrobasilar artery occlusion (BEST).Lancet Neurol. 2020; 19:115–122. doi: 10.1016/S1474-4422(19)30395-3CrossrefMedlineGoogle Scholar11. Qiu Z, Li F, Sang H, Luo W, Liu S, Liu W, Guo Z, Li H, Sun D, Huang W, et al; RESCUE BT Trial Investigators. Effect of intravenous tirofiban vs placebo before endovascular thrombectomy on functional outcomes in large vessel occlusion stroke.JAMA. 2022; 328:543–553. doi: 10.1001/jama.2022.12584CrossrefGoogle Scholar12. van der Steen W, van de Graaf RA, Chalos V, Lingsma HF, van Doormaal PJ, Coutinho JM, Emmer BJ, de Ridder I, van Zwam W, van der Worp HB, et al; MR CLEAN-MED investigators. Safety and efficacy of aspirin, unfractionated heparin, both, or neither during endovascular stroke treatment (MR CLEAN-MED).Lancet. 2022; 399:1059–1069. doi: 10.1016/S0140-6736(22)00014-9CrossrefGoogle Scholar13. Renu A, Millan M, San Roman L, Blasco J, Marti-Fabregas J, Terceno M, Amaro S, Serena J, Urra X, Laredo C, et al; CHOICE Investigators. Effect of intra-arterial alteplase vs placebo following successful thrombectomy on functional outcomes in patients with large vessel occlusion acute ischemic stroke.JAMA. 2022; 327:826–835. doi: 10.1001/jama.2022.1645CrossrefGoogle Scholar14. Anderson CS, Huang Y, Lindley RI, Chen X, Arima H, Chen G, Li Q, Billot L, Delcourt C, Bath PM, et al. Intensive blood pressure reduction with intravenous thrombolysis therapy for acute ischaemic stroke (ENCHANTED).Lancet. 2019; 393:877. doi: 10.1016/S0140-6736(19)30038-8CrossrefMedlineGoogle Scholar15. Yang P, Song L, Zhang Y, Zhang X, Chen X, Li Y, Sun L, Wan Y, Billot L, Li Q, et al; ENCHANTED2/MT Investigators. Intensive blood pressure control after endovascular thrombectomy for acute ischaemic stroke (ENCHANTED2/MT).Lancet. 2022; 400:1585–1596. doi: 10.1016/S0140-6736(22)01882-7CrossrefGoogle Scholar16. Mistry EA, Nguyen TN. Blood pressure goals after mechanical thrombectomy.Lancet. 2022; 400:1558–1559. doi: 10.1016/S0140-6736(22)01987-0CrossrefGoogle Scholar17. Warach S, Ranta A, Kim J, Song S, Wallace A, Beharry J, Gibson D, Cadilhac D, Bladin C, Kleinig T, et al. The comparative effectiveness of routine tenecteplase versus alteplase in acute ischaemic stroke.SSRN. 2022. https://ssrn.com/abstract=4231226.Google Scholar18. Campbell BCV, Mitchell PJ, Churilov L, Yassi N, Kleinig TJ, Dowling RJ, Yan B, Bush SJ, Dewey HM, Thijs V, et al. Tenecteplase versus alteplase before thrombectomy for ischemic stroke.NEJM. 2018; 378:1573–1582. doi: 10.1056/NEJMoa1716405CrossrefMedlineGoogle Scholar19. Campbell BCV, Mitchell PJ, Churilov L, Yassi N, Kleinig TJ, Dowling RJ, Yan B, Bush SJ, Thijs V, Scroop R, et al; EXTEND-IA TNK Part 2 investigators. Effect of intravenous tenecteplase dose on cerebral reperfusion before thrombectomy in patients with large vessel occlusion ischemic stroke.JAMA. 2020; 323:1257–1265. doi: 10.1001/jama.2020.1511CrossrefMedlineGoogle Scholar eLetters(0)eLetters should relate to an article recently published in the journal and are not a forum for providing unpublished data. Comments are reviewed for appropriate use of tone and language. Comments are not peer-reviewed. Acceptable comments are posted to the journal website only. Comments are not published in an issue and are not indexed in PubMed. Comments should be no longer than 500 words and will only be posted online. References are limited to 10. Authors of the article cited in the comment will be invited to reply, as appropriate.Comments and feedback on AHA/ASA Scientific Statements and Guidelines should be directed to the AHA/ASA Manuscript Oversight Committee via its Correspondence page.Sign In to Submit a Response to This Article Previous Back to top Next FiguresReferencesRelatedDetailsCited By Klein P, Huo X, Chen Y, Abdalkader M, Qiu Z, Nagel S, Raymond J, Liu L, Siegler J, Strbian D, Field T, Yaghi S, Qureshi M, Demeestere J, Puetz V, Berberich A, Michel P, Fischer U, Kaesmacher J, Yamagami H, Alemseged F, Tsivgoulis G, Schonewille W, Hu W, Liu X, Li C, Ji X, Drumm B, Banerjee S, Sacco S, Sandset E, Kristoffersen E, Slade P, Mikulik R, Romoli M, Diana F, Krishnan K, Dhillon P, Lee J, Kasper E, Dasenbrock H, Ton M, Masiliūnas R, Arsovska A, Marto J, Dmytriw A, Regenhardt R, Silva G, Siepmann T, Sun D, Sang H, Diestro J, Yang P, Mohammaden M, Li F, Masoud H, Ma A, Raynald , Ganesh A, Liu J, Meyer L, Dippel D, Thomalla G, Parsons M, Qureshi A, Goyal M, Yoo A, Lapergue B, Zaidat O, Chen H, Campbell B, Jovin T, Nogueira R, Miao Z, Saposnik G and Nguyen T (2023) Specialist Perspectives on the Imaging Selection of Large Vessel Occlusion in the Late Window, Clinical Neuroradiology, 10.1007/s00062-023-01284-0 February 2023Vol 54, Issue 2 Advertisement Article InformationMetrics © 2023 American Heart Association, Inc.https://doi.org/10.1161/STROKEAHA.122.041254PMID: 36689599 Manuscript receivedNovember 30, 2022Manuscript acceptedDecember 7, 2022Originally publishedJanuary 23, 2023 Keywordsbasilar artery reperfusion ◼ stroke ◼ tenecteplase ◼ thrombectomyPDF download Advertisement SubjectsIschemic Stroke